Company intelligence / Profile preview
Innolake Biopharma
Hangzhou, Zhejiang, Chinainnolake.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Innolake Biopharma is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative medicines for oncology and autoimmune diseases. Headquartered in Hangzhou, China, the company was founded in 2020 by industry veteran Dr. Robert Zhang, who previously led R&D at Hengrui Medicine. Innolake utilizes its proprietary technology platforms to advance a robust pipeline featuring antibody-drug conjugates (ADCs), bispecific antibodies, and novel small molecules. The company's lead assets, including a PD-L1/CD47 bispecific antibody and a Claudin 18.2 ADC, are currently undergoing clinical evaluation. With strong backing from top-tier venture capital firms, Innolake is positioned to become a leader in the next generation of precision medicine.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small moleculeAntibody-drug conjugateBispecific monoclonal antibodyMonoclonal antibody
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Innolake Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Innolake Biopharma.